early bronchoscopic diagnosis of concomitant tuberculosis and pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.

NLM AIDSLINE Early bronchoscopic diagnosis of concomitant tuberculosis and Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. Albino JA; Shapiro JM; National Tuberculosis Center, LMDNJ-New Jersey
March 30, 1997

J Assoc Acad Minor Phys. 1996;7(4):99-103. Unique Identifier : AIDSLINE Pulmonary infections, including mixed infections, are common in patients with human immunodeficiency virus (HIV), and a specific diagnosis is desirable to direct therapy. In a retrospective study of patients suspected of having Pneumocystis carinii pneumonia, we examined the usefulness of fiberoptic bronchoscopy in the immediate diagnosis of tuberculosis. In 267 patients, pneumocystis pneumonia was diagnosed in 115 (43%), of whom 5 (4%) also had concomitant tuberculosis. Bronchoalveolar lavage gave an immediate diagnosis of tuberculosis by positive acid-fast bacilli stain in 3 patients, while the transbronchial biopsy was suggestive in a fourth. Four of these patients developed respiratory failure, and 2 died. In patients with pneumocystis pneumonia, respiratory failure was significantly more common in those with tuberculosis (P = .0077). In 156 (58%) of the 267 cases, bronchoalveolar lavage was negative for pneumocystis pneumonia, while tuberculosis was diagnosed in 14 (9%), and an immediate diagnosis was made in 10 (71%). In a series of HIV-infected patients suspected mainly of having pneumocystis pneumonia, tuberculosis was found instead in 19 (7%), and both diseases were present in 5 (2%). Bronchoscopy provided an early diagnosis of tuberculosis in 63%. Patients with concomitant pneumocystis pneumonia and tuberculosis had a high rate of respiratory failure. Adult AIDS-Related Opportunistic Infections/COMPLICATIONS/DIAGNOSIS Bronchoscopy Female Human Male Middle Age Pneumonia, Pneumocystis carinii/COMPLICATIONS/DIAGNOSIS Retrospective Studies Sensitivity and Specificity Time Factors Tuberculosis/COMPLICATIONS/DIAGNOSIS JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine India Widens Price Control Over Medicines Health group didn't disclose HIV tests, apologizes As Hepatitis C Spreads, Scotland Steps In Russia has 'no anti-AIDS strategy': official Uganda: Over 600 Circumcised in Masaka 1 new hepatitis case in Okla. public health scare NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs WASHINGTON: Front Porch -- Share Your Experiences with Tuberculosis PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents NORTH KOREA: North Korea Sees Surge of Drug-Resistant Tuberculosis Experimental Gilead drug effective in early-stage leukemia trial Public Meeting on HIV Patient-Focused Drug Development and HIV Cure Research: June 14, 2013 Legal help for AIDS patients THE NETHERLANDS: High Prevalence of Oral HPV Infection in Dutch Gay Men WHO says Cambodia can end HIV infections by 2020 UNITED STATES: Pretreatment Anemia Raises Mortality Risk Among HCV/HIV Coinfected Patients New Research Uncovers Willful Misrepresentation of Medical Data in Creation of AIDS "Patient Zero" Myth
Information in this article was accurate in March 30, 1997. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.